Who to call at Northwest Biotherapeutics, and when

Fundz watches for the moments Northwest Biotherapeutics starts buying, and tells you who to reach.

An alert the day Northwest Biotherapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Northwest Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Northwest Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Northwest Biotherapeutics Partners with SPIMACO for Collaboration in Saudi Arabia on DCVax® Products.

Aug 06, 2026

Contract Type

partnership

BethesdaBiotechnologyHealthcareresearch

Description

Northwest Biotherapeutics has entered into a non-binding Memorandum of Understanding with the Saudi Pharmaceutical Industries and Medical Appliance Company (SPIMACO) to collaborate on bringing its DCVax®-L product to Saudi Arabia. The partnership aims to establish a framework for approval, commercialization, and technology transfer for DCVax®-L products.

Quick answer

Northwest Biotherapeutics Partners with SPIMACO for Collaboration in Saudi Arabia on DCVax® Products. (August 6, 2026). Northwest Biotherapeutics is based in Bethesda, Maryland, United States.

What agreement did Northwest Biotherapeutics announce on August 6, 2026?: Northwest Biotherapeutics has entered into a non-binding Memorandum of Understanding with the Saudi Pharmaceutical Industries and Medical Appliance Company (SPIMACO) to collaborate on bringing its DCVax®-L product to Saudi Arabia. The partnership aims to establish a framework for approval, commercialization, and technology transfer for DCVax®-L products.
What does Northwest Biotherapeutics do?: Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind...
Where is Northwest Biotherapeutics based?: Northwest Biotherapeutics is based in Bethesda, Maryland, United States.

Source: Fundz verified event record.

Company Information

Company

Northwest Biotherapeutics

Location

4800 MONTGOMERY LANE,

Bethesda, Maryland, United States

About

Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both North America and Europe. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines. The Company's lead program is a 331-patient Phase III trial of DCVax®-L for newly diagnosed Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal form of brain cancer, and is an "orphan disease." This Phase III trial reached data lock and the Company is actively continuing to move toward announcement of top line data. The Company has also developed DCVax®-Direct for inoperable solid tumor cancers. It has completed a 40-patient Phase I trial and, as resources permit, plans to pursue Phase II trials. The Company previously conducted a Phase I/II trial with DCVax-L for advanced ovarian cancer together with the University of Pennsylvania.